Nurses Programme

Session 1
Time Topic Presenter Chairperson
10h55 – 11h00 Welcome Sr Natasha Nunan Natasha Nunan
11h00 – 11h25 ? Leukemia Dr Gugu Jali
11h25 – 11h50 The new kid on the block – Vaccinations in Heamatology Sr Drina Heyns
11h50 – 12h00 Panel Discussion and Q & A  
12h00 – 13h00  Lunch
Session 2
13h00 – 13h25 Red flags in Heamatology. Sepsis, side effects and saving lifes. Dr Jasmine Rankin Drina Heyns
13h25 – 13h50 Small Actions. Safer Care. Better Outcomes.” Central Venous Access Device care Sr Natasha Nunan
13h55 – 14h20 Antimicrobial locks Stephanie Viljoen
14h25 – 14h50 Optimizing blood product infusion safety and current national infusion guidelines in SA. Sr Andrea Brummer
14h50 – 15h00 Panel Discussion and Q & A  
15h00 – 15h30 Refreshment Break
Session 3
15h30 – 15h50 Palliative care in Heamatology Dr  Curwin Matabula Natasha Nunan
15h50 – 16h10 Healing the Healer: Supporting the nurse, Strengthening Care    Natasha & Drina
16h10 – 16h20 Blood SA  
16h20 – 16h30 Campaigning for Cancer – Call to Action  
  Closure of the session  

About AstraZeneca

AstraZeneca is a science-led, patient-focused biopharmaceutical company committed to transforming healthcare and improving outcomes. We believe science, powered by digital, data and AI, is key to addressing the world’s most pressing healthcare challenges.

We strive to improve access to life-changing medicines and pioneering solutions, while also supporting earlier detection, integrated care pathways, and stronger health systems so more people can receive the right care at the right time. Powered by scientific innovation, and increasingly enabled by digital, data and AI, we are helping redefine cancer care, improve outcomes in chronic diseases, and expand access to care in a sustainable and responsible way.

Activity ID: ZA-6886; Expiry date: 30 June 2028

https://www.astrazeneca.com/country-sites/african-cluster.html

About Novo Nordisk

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built on our heritage in diabetes. Through scientific innovation, expanded access to medicines, and partnerships across healthcare and technology, we help bring meaningful solutions to patients worldwide. Novo Nordisk employs about 67,900 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 304 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter, Instagram and YouTube.

Loading...